- Home
- CHE vs ASND Comparison
CHE vs ASND Comparison
Compare CHE & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHE
- ASND
- Stock Information
- Founded
- CHE 1970
- ASND 2006
- Country
- CHE United States
- ASND Denmark
- Employees
- CHE N/A
- ASND N/A
- Industry
- CHE Medical/Nursing Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CHE Health Care
- ASND Health Care
- Exchange
- CHE Nasdaq
- ASND Nasdaq
- Market Cap
- CHE 8.8B
- ASND 9.1B
- IPO Year
- CHE N/A
- ASND 2015
- Fundamental
- Price
- CHE $571.36
- ASND $151.25
- Analyst Decision
- CHE Buy
- ASND Strong Buy
- Analyst Count
- CHE 1
- ASND 16
- Target Price
- CHE $674.00
- ASND $213.88
- AVG Volume (30 Days)
- CHE 131.0K
- ASND 564.4K
- Earning Date
- CHE 04-23-2025
- ASND 05-01-2025
- Dividend Yield
- CHE 0.35%
- ASND N/A
- EPS Growth
- CHE 10.48
- ASND N/A
- EPS
- CHE 20.53
- ASND N/A
- Revenue
- CHE $2,488,997,000.00
- ASND $398,509,511.00
- Revenue This Year
- CHE $9.04
- ASND $62.61
- Revenue Next Year
- CHE $6.68
- ASND $72.16
- P/E Ratio
- CHE $27.88
- ASND N/A
- Revenue Growth
- CHE 8.52
- ASND 12.06
- 52 Week Low
- CHE $512.12
- ASND $111.09
- 52 Week High
- CHE $623.61
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- CHE 46.01
- ASND 41.32
- Support Level
- CHE $568.44
- ASND $164.24
- Resistance Level
- CHE $583.37
- ASND $183.00
- Average True Range (ATR)
- CHE 14.07
- ASND 7.88
- MACD
- CHE 0.39
- ASND -1.35
- Stochastic Oscillator
- CHE 60.32
- ASND 0.44
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.